Patents by Inventor Rodney Benjamin

Rodney Benjamin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS
    Publication number: 20230240984
    Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
    Type: Application
    Filed: October 28, 2022
    Publication date: August 3, 2023
    Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
  • DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS
    Publication number: 20200297625
    Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
    Type: Application
    Filed: January 27, 2020
    Publication date: September 24, 2020
    Applicant: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
  • Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
    Patent number: 10596109
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: March 24, 2020
    Assignee: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
  • DIMETHYL SULFOXIDE (DMSO) OR DMSO AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT INFECTIOUS DISEASES
    Publication number: 20180214373
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Application
    Filed: December 1, 2017
    Publication date: August 2, 2018
    Applicant: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
  • DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS
    Publication number: 20180092838
    Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
    Type: Application
    Filed: November 22, 2017
    Publication date: April 5, 2018
    Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
  • Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
    Patent number: 9855212
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: January 2, 2018
    Assignee: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
  • Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
    Patent number: 9839609
    Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: December 12, 2017
    Assignee: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
  • METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS
    Publication number: 20130338130
    Abstract: Embodiments of the invention relate generally to the use of compositions comprising methylsulfonylmethane (MSM), and one or more therapeutic agents, for the treatment of drug-sensitive and drug resistant microorganisms. In several embodiments, such compositions are effective in treating drug resistant infectious diseases, for example, MRSA.
    Type: Application
    Filed: August 19, 2013
    Publication date: December 19, 2013
    Applicant: Biogenic Innovations, LLC
    Inventors: Rodney Benjamin, Anthony L. Keller, Jeffrey Varelman
  • DIMETHYL SULFOXIDE (DMSO) OR DMSO AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT INFECTIOUS DISEASES
    Publication number: 20130045941
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Application
    Filed: October 29, 2010
    Publication date: February 21, 2013
    Applicant: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
  • DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS
    Publication number: 20120207827
    Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
    Type: Application
    Filed: October 29, 2010
    Publication date: August 16, 2012
    Applicant: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
  • Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms
    Patent number: 8217085
    Abstract: Embodiments of the invention relate generally to the use of compositions comprising methylsulfonylmethane (MSM), and one or more therapeutic agents, for the treatment of drug-sensitive and drug resistant microorganisms. In several embodiments, such compositions are effective in treating drug resistant infectious diseases, for example, MRSA.
    Type: Grant
    Filed: February 17, 2012
    Date of Patent: July 10, 2012
    Assignee: Biogenic Innovations, LLC
    Inventors: Rodney Benjamin, Jeffrey Varelman, Anthony Keller
  • METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS
    Publication number: 20120149672
    Abstract: Embodiments of the invention relate generally to the use of compositions comprising methylsulfonylmethane (MSM), and one or more therapeutic agents, for the treatment of drug-sensitive and drug resistant microorganisms. In several embodiments, such compositions are effective in treating drug resistant infectious diseases, for example, MRSA.
    Type: Application
    Filed: February 17, 2012
    Publication date: June 14, 2012
    Inventors: Rodney Benjamin, Jeffrey Varelman, Anthony Keller
  • METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS
    Publication number: 20110152231
    Abstract: Embodiments of the invention relate generally to the use of compositions comprising methylsulfonylmethane (MSM), and one or more therapeutic agents, for the treatment of drug-sensitive and drug resistant microorganisms. In several embodiments, such compositions are effective in treating drug resistant infectious diseases, for example, MRSA.
    Type: Application
    Filed: October 29, 2010
    Publication date: June 23, 2011
    Inventors: Rodney Benjamin, Anthony L. Keller, Jeffrey Varelman